Parkinson's Disease: domographics demand better treatments

Article Abstract:

The article details basic treatments for the disease and explores causes. The most effective agent against the disease is a combination of levodopa and peripheral dopa decarboxylase inhibitor (carbidopa).

Brief Article

---

New Dopamine Agonists Improve Parkinson's Disease Therapy

Article Abstract:

Pharmacia & Upjohn's Mirapex and SmithKline Beechman's Requip have proven to benefit Parkinson's patients. Sales in 2000 are expected to be about $200m and $125m respectively.

Market information - general, Forecasts, trends, outlooks, Marketing procedures, Company Planning/Goals, Anti-Parkinsons Preparations, Abstract, Pharmacia and Upjohn Inc., PNU, Antiparkinson agents, Requip (Medication), SmithKline Beecham. Pharmaceuticals, Mirapex (Medication), Trihexyphenidyl

---

Stroke: the major cause of disability among adults

Article Abstract:

The article offers information on the various types of stroke and their causes and treatment.

Similar abstracts:

• Abstracts: Infectious disease: Kaiser Permanente: resistance test inproves HIV treatment outcome and cuts costs
• Abstracts: Advance directives and medical treatment at the end of life
• Abstracts: Marketing-driven change management. Strategic marketing and communications audits. Demographic change is faster than you think
• Abstracts: Best practices in managing organized delivery systems. Organizational culture: the critical link between strategy and results
• Abstracts: An emergent merger; the combination of two Boston ERs may set a record for speed. Burning issues

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.